OliX Pharmaceuticals, Inc (KOSDAQ:226950)
131,900
-5,900 (-4.28%)
Aug 11, 2026, 3:30 PM KST
153.17% (1Y)
| Market Cap | 2.90T +181.4% |
| Revenue (ttm) | 17.26B +193.3% |
| Net Income | -12.25B |
| EPS | -596.21 |
| Shares Out | 21.06M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 319,729 |
| Open | 136,500 |
| Previous Close | 137,800 |
| Day's Range | 128,000 - 141,400 |
| 52-Week Range | 48,850 - 217,000 |
| Beta | 0.46 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |